Vishal Chandra to Humans
This is a "connection" page, showing publications Vishal Chandra has written about Humans.
Connection Strength
0.204
-
Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors. Biomed Pharmacother. 2023 May; 161:114422.
Score: 0.048
-
Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis. Oncotarget. 2016 Nov 08; 7(45):74286-74302.
Score: 0.031
-
MicroRNA aberrations: An emerging field for gallbladder cancer management. World J Gastroenterol. 2016 Feb 07; 22(5):1787-99.
Score: 0.029
-
Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016 Jan; 27(1):e8.
Score: 0.029
-
Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing. AAPS J. 2023 Dec 12; 26(1):5.
Score: 0.013
-
Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia. J Pharm Sci. 2018 02; 107(2):638-646.
Score: 0.008
-
A Hyaluronic Acid-Rich Node and Duct System in Which Pluripotent Adult Stem Cells Circulate. Stem Cells Dev. 2015 Oct 01; 24(19):2243-58.
Score: 0.007
-
Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells. Toxicol Appl Pharmacol. 2014 Oct 15; 280(2):323-34.
Score: 0.007
-
Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors a- and ß-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Steroids. 2013 Nov; 78(11):1071-86.
Score: 0.006
-
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways. PLoS One. 2013; 8(6):e66246.
Score: 0.006
-
(-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation. J Nutr Biochem. 2013 Jun; 24(6):940-7.
Score: 0.006
-
Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer. Surg Oncol. 2012 Dec; 21(4):281-92.
Score: 0.006
-
Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer. Bioorg Med Chem. 2009 Oct 01; 17(19):6832-40.
Score: 0.005
-
Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem. 2009 Jun 01; 17(11):3847-56.
Score: 0.005